|
Insulin Resistance and Insulin Secretion Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Insulin Resistance and Insulin Secretion conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Insulin Resistance and Insulin Secretion Clinical research trials and Insulin Resistance and Insulin Secretion healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Insulin Resistance and Insulin Secretion. Insulin Resistance and Insulin Secretion Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Insulin Resistance and Insulin Secretion clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Insulin Resistance and Insulin Secretion condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Insulin Resistance and Insulin Secretion  Insulin Resistance and Insulin Secretion
Insulin Resistance and Insulin Secretion
For Condition: Diabetes Mellitus, Type 2
Status: Recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: This is a pilot study to examine the prevalence of metabolic risk factors (impaired insulin release and impaired insulin sensitivity) for type 2 diabetes mellitus in children and adults from a population that is at high risk for this disease. We hypothesize that at least one of these pre-diabetic traits will be evident in a large proportion of relatives of known type 2 diabetic children as compared to a control group of subjects without a family history of type 2 diabetes. By isolating these traits, it will be possible to determine the relative contributions of genes and environment to each trait and to identify those at risk for subsequent development of type 2 diabetes by virtue of having one trait. Ultimately, those individuals at risk, especially those with impaired insulin release, would hopefully benefit from intervention to prevent the weight gain that will 'unmask' their underlying pancreatic dysfunction and thus prevent or retard the development of type 2 diabetes.
Details:
Eligibility:
Study Type: Interventional, Prevention, Non-Randomized, Single Blind, Uncontrolled, Single Group Assignment, Bio-equivalence Study
Minimum Age/Maximum Age: 10 Years/20 Years
Genders: Both
Protocol Entry Criteria: Ascertainment criteria for probands: - age 10-20 years and - obesity (BMI >85% for sex and age) - diabetic criteria as described above or family history (first or second degree relative) with type 2 diabetes
Total Enrollment: 200
Location and Contact Information:
Columbia Presbyterian Medical Center/ Irving Center *Completed*
New York City, New York, 10032
United States
Completed
Russ Berrie Pavilion *Recruiting*
New York City, New York, 10032
United States
Recruiting Michael Rosenbaum
Additional Information:
Study ID Numbers: 9777;
Study Start Date:
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073294
Other Diabetes Mellitus, Type 2 Studies:
1. Computer-assisted diabetes self-management interventions
2. Lifestyle interventions to reduce diabetes risk
3. Insulin Resistance and Insulin Secretion
4. Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model
5. Effect of AC2993 Compared with Insulin Glargine in Patients with Type 2 Diabetes Also Using Combination Therapy with Sulfonylurea and Metformin
Related Studies:
Other Diabetes Mellitus, Type 2 Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Insulin Resistance and Insulin Secretion
|
|
|
|
|
|
|
|
